References
Cowell JK, ed.Molecular Genetics of Cancer. 2nd ed. San Diego: Academic Press, 2001.
Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer.Nature 1998;392:402–5.
Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.N Engl J Med 1999;340:77–84.
Haber D. Prophylactic oophorectomy to reduce the risk of ovarian and breast cancer carrioers of BRCA mutations.N Engl J Med 2002;346:1660–2.
Weitzel JN, McCahill LE. The power of genetics to target surgical prevention (editorial).N Engl J Med 2001;344:1942–4.
Grady WM, Peck RM. Hereditary diffuse gastric cancer: more answers or more question?Gastroenterology 2002;122:830–2.
Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.Gastroenterology 2001;121:1348–53.
Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med 2001;345:159–64.
Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.N Engl J Med 2002;346:1609–15.
Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carrires of BRCA1 or BRCA2 mutations.N Engl J Med 2002;346:1616–22.
Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.N Engl J Med 2001;344:1904–9.
Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?Cancer 2001;92:181–7.
Frost MH, Schaid DJ, Sellers TA, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.JAMA 2000;284:319–24.
Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women (abstract).Am J Public Health 1997;87:676–80.
Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women (abstract).N Engl J Med 1987;316:1105–10.
Aitken JM, Hart DM, Anderson JB, Lindsay R, Smith DA, Speirs CF. Osteoporosis after oophorectomy for non-malignant disease in premenopausal women.Br Med J 1973;2:325–8.
Fry A, Busby-Earle C, Rush R, Cull A. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer.Psychooncology 2001;10:231–41.
Roukos DH. Current status and future perspectives in gastric cancer management.Cancer Treat Rev 2000;26:243–55.
Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients-is reconstruction with a reservoir worthwhile?Nutrition 1999;15:677–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roukos, D.H., Kappas, A.M. & Tsianos, E. Role of surgery in the prophylaxis of hereditary cancer syndromes. Annals of Surgical Oncology 9, 607–609 (2002). https://doi.org/10.1007/BF02574474
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02574474